Table 2.

Comparison of clinicopathological features and expression levels of miR-200a, miR-141 and miR-205 in ECs and in NECs

Variable	Log2 (Relative Quantity) Mean ± SE
		ECs			NECs
	miR-200a	miR-141	miR-205	miR-200a	miR-141	miR-205
Grade (ECs)
Low	3.96 ± 0.35	3.74 ± 0.33	4.29 ± 0.44	/	/	/
High	3.44 ± 0.61	3.17 ± 0.58	4.93 ± 0.53	/	/	/
p	0.447	0.369	0.415	/	/	/
Myometrial invasion
< 1/2	3.57 ± 0.36	3.27 ± 0.35	4.29 ± 0.41	4.86 ± 1.13	4.16 ± 0.90	4.05 ± 0.66
≥ 1/2	3.50 ± 0.72	3.63 ± 0.49	4.26 ± 1.04	5.65 ± 1.43	4.39 ± 1.09	4.35 ± 0.88
p	0.921	0.622	0.975	0.663	0.876	0.787
Lymph node metastases
No	4.32 ± 0.46	3.72 ± 0.45	4.06 ± 0.62	5.37 ± 1.00	4.71 ± 0.83	4.45 ± 0.60
Yes	3.82 ± 1.20	3.45 ± 1.03	4.00 ± 0.90	5.74 ± 1.22	4.85 ± 0.78	2.52 ± 1.38
p	0.679	0.818	0.971	0.884	0.947	0.233
Vessel invasion
No	3.63 ± 0.34	3.38 ± 0.33	4.27 ± 0.44	4.93 ± 1.08	4.18 ± 0.85	4.24 ± 0.64
Yes	3.16 ± 1.01	3.15 ± 0.73	4.38 ± 0.70	5.83 ± 1.40	4.45 ± 1.07	3.93 ± 0.87
p	0.599	0.780	0.916	0.660	0.869	0.798
Stage
I and II	3.62 ± 0.33	3.32 ± 0.32	4.26 ± 0.42	4.31 ± 1.08	3.81 ± 0.82	4.06 ± 0.55
III and IV	3.09 ± 1.22	3.49 ± 0.82	4.44 ± 0.76	7.38 ± 1.28	5.38 ± 1.25	4.44 ± 1.27
p	0.609	0.865	0.887	0.119	0.312	0.746
ER
Negative	3.99 ± 0.72	3.00 ± 0.78	3.41 ± 0.91	6.09 ± 0.83	4.44 ± 0.76	4.40 ± 0.59
Positive	3.77 ± 0.34	3.75 ± 0.29	4.79 ± 0.36	4.01 ± 1.80	4.35 ± 1.27	4.41 ± 0.92
p	0.763	0.277	0.103	0.235	0.950	0.994
PR
Negative	3.54 ± 0.75	3.04 ± 0.79	3.01 ± 0.91	6.01 ± 0.76	4.83 ± 0.70	4.26 ± 0.57
Positive	3.89 ± 0.33	3.73 ± 0.29	4.88 ± 0.36	3.64 ± 2.26	3.26 ± 1.51	4.81 ± 1.02
p	0.644	0.326	0.028	0.206	0.291	0.624